Latest filing published 03 Oct 2026 for BioSyent Inc., €7,655. Read the official filing
Peter Douglas Lockhard discloses dealings in BioSyent Inc. to SEDI. The record holds 19 filings, for trades running from 25 May 2026 to 1 October 2026.
The open-market record consists of 15 sales worth €37k, with no purchase. Other entries cover 4 option exercises.
On 3 October 2026 came the latest disclosure, an option exercise for €7,655 in BioSyent Inc. Filings reach the SEDI feed a median of 1 day after the trade. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations